All News #Library
Rare Diseases
FDA Grants Orphan Drug Designation to ERAS-801 for Malignant Glioma
23 Jun 2023 //
ONCOLIVE
Erasca Granted FDA Orphan Desig for CNS-Penetrant EGFR Inhibitor ERAS-801
22 Jun 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support